None of our major shareholders have different voting rights from other shareholders. To our knowledge, as of September 2, 2023, 55,684,252 ordinary shares, representing 89.8% of our issued and outstanding ordinary shares, were held by five record holders in the United States, including Cede & Co., a nominee of The Depository Trust Company. Except as described hereof, we are not aware of any arrangement that may, at a subsequent date, result in a change of control of the Company.
F. | Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation |
Not applicable.
ITEM 7. | MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS |
Please refer to “Item 6. Directors, Senior Management and Employees—E. Share Ownership.”
B. | Related Party Transactions |
Transactions with China Techenergy Co., Ltd.
China Techenergy Co., Ltd. (“China Techenergy”), an equity investee of Hollysys, which are used for non-safety operations control in the nuclear power industry is 40% owned by Beijing Hollysys. China Techenergy incorporates our non-safety automation control systems with their proprietary safety automated control systems to provide an overall automation and control system for nuclear power stations in China. We are not a party to the integrated sales contracts executed between China Techenergy and its customers. Our pro rata shares of the intercompany profits and losses are eliminated until realized through a sale to outside parties, as if China Techenergy were a consolidated subsidiary.
The transactions with China Techenergy included (i) sales of goods and integrated solutions, amounting to USD 8.5 million, USD 5.1 million, and USD 12.2 million for the years ended June 30, 2021, 2022, and 2023, respectively, (ii) amounts due to China Techenergy of USD 2.0 million, and USD 2.1 million as of June 30, 2022, and 2023, respectively, and (iii) amounts due from China Techenergy of USD 17.5 million, and USD 16.3 million as of June 30, 2022, and 2023, respectively. The sales of goods and integrated solutions we provided to China Techenergy are conducted on an arm’s length basis with similar unrelated parties. There is no ongoing contractual or commitments arrangement with China Techenergy.
Transactions with Beijing Hollycon Medicine & Technology. Co., Ltd.
Beijing Hollycon Medicine & Technology. Co., Ltd. (“Hollycon”), an equity investee of Hollsys, which incorporates our products with their automated systems to provide an integrated automation and control system to their customer is 30% directly owned by Hollysys Group Co., Ltd.
The transactions with Hollycon included (i) sales of goods and integrated solutions, amounting to USD0.9 million, USD 0.2 million, and USD 0.2 million for the years ended June 30, 2021, 2022, and 2023, respectively, (ii) purchase of goods and services, amounting to nil, USD 0.6 million, and USD 0.1 million for the years ended June 30, 2021, 2022, and 2023, respectively, (iii) other income, amounting to USD 0.5 million, USD 2.4 million, and USD 1.2 million for the years ended June 30, 2021, 2022, and 2023, respectively, (iv) amounts due to Hollycon of nil, and USD 0.2 million as of June 30, 2022, and 2023, respectively, and (v) amounts due from Hollycon of USD 15.1 million, and USD 14.0 million as of June 30, 2022, and 2023, respectively. The sales of goods and integrated solutions we provided to Hollycon and purchase of goods and services from Hollycon are conducted on an arm’s length basis with similar unrelated parties. There is no ongoing contractual or commitments arrangement with Hollycon.
Other transactions with related parties
Other transactions with Ningbo Hollysys, an equity investee of Hollysys, included (i) sales of goods and integrated solutions, amounting to USD0.3 million, USD 1.0 million, and USD 2.4 million for the years ended June 30, 2021, 2022, and 2023, respectively, (ii) purchase of goods and services, amounting to USD 3.1 million, USD 1.1 million, and USD 1.8 million for the years ended June 30, 2021, 2022, and 2023, respectively, (iii) other income, amounting to USD 2.3 million, USD 0.1 million, and USD 0.7 million for the years ended June 30, 2021, 2022, and 2023, respectively, (iv) purchase of research and development service, amounting to USD 0.2 million, USD 0.2 million, and USD 0.1 million for the years ended June 30, 2021, 2022, and 2023, respectively, (v) amounts due to Ningbo Hollysys of USD 4.3 million, and USD 3.9 million as of June 30, 2022, and 2023, respectively, and (vi) amounts due from Ningbo Hollysys of USD 0.3 million, and USD 0.6 million as of June 30, 2022, and 2023, respectively. The above transactions with Ningbo Hollysys are conducted on an arm’s length basis with similar unrelated parties. There is no ongoing contractual or commitments arrangement with Ningbo Hollysys.
We also have transactions with other equity investees including Beijing Hollysys Digital Technology Co., Ltd. For more details, please refer to the related parties footnote disclosure in our audited financial statements included in this annual report.
C. | Interests of Experts and Counsel |
Not applicable.
94